Benjamin Edwards’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Benjamin Edwards's RXRX Position: Q3 2026 in Review
Benjamin Edwards reduced its Recursion Pharmaceuticals (RXRX) stake by 3.7% in Q3 2026, selling an estimated $21K and leaving 162,341 shares worth $670K. The position accounts for 0.01% of the portfolio, ranked #954.
Benjamin Edwards first reported a position in RXRX in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.07M in Q4 2024. 264 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Benjamin Edwards held 162,341 shares of Recursion Pharmaceuticals worth $670K as of Q3 2026.
- Benjamin Edwards sold 6,199 Recursion Pharmaceuticals shares in Q3 2026, an estimated $21K.
- Recursion Pharmaceuticals made up 0.01% of Benjamin Edwards's portfolio in Q3 2026, its #954 holding.
- Benjamin Edwards first reported a position in Recursion Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
- Benjamin Edwards's Recursion Pharmaceuticals position peaked at $1.07M in Q4 2024.
- 264 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.